James Temple

Organizers are asking participants to delay their arrival until Tuesday.

The company stressed the incident presented no danger and was a normal part of the research process.

Genomics and other tech tools could help drive down the soaring cost of drug approval, says Ian Clark.

The DFJ-led round follows a series of deep learning investments, acquisitions and hires.

Could invisibility cloaks be far behind? (Yes.)

The patent trolling firm is making “operational changes.”

Project Loon, hoverboards, teleportation and more.